30 closest matches · ranked by relevance
Respiratory Distress Syndrome · Bronchopulmonary Dysplasia
Primary: Changes in the Measurements of Functional Residual Capacity (FRC) in Randomized Premature Infants — 12.6; 6.4; 27.2; 17.1 mL — p=<0.05
ALS
Primary: Standard PFT - Forced Vital Capacity — 72.7 Percent Predicted FVC
ALS
Primary: Date of Identification of Noninvasive Ventilation (NIV) Need From rPFT Monitoring — 176 days after enrollment
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Left Ventricular End Diastolic Volume Index (LVEDVI) in the 6th Week of Treatment — 2.855; 2.317 Millilitre/ meter^2 (mL/m^2) — p=0.6331
COPD
Primary: Gas Trapping Measured During Washout of the Perfluorinated Gas Mixture. — 0.718; 0.541; 0.308; 0.451 percentage of total lung volume — p=<0.0001
Oxygen Toxicity
Primary: Change in Percentage Predicted Forced Expiratory Volume in One Second (FEV1%) — 88.0; 85.9; 87.4; 84.6 Percentage of FEV1
Heart Failure
Primary: Mean Change in Pulmonary Artery Pressure (PAP) Due to Change in Posture — 27.7 mmHg — p=0.429
Pompe Disease
Primary: Inspiratory Load Compensation - Inspiratory Volume — 288.41; 554.34; 743.71; 927.57 mL
Covid19 · Respiratory Function Loss · Coronavirus Infection
Primary: Change in Peak Expiratory Flow (Absolute Value) — 175; 160 ml/min — p=0.374
Chronic Obstructive Pulmonary Disease (COPD) · Heart Failure
Primary: Function Capability — 349; 338 meters
Pulmonary Surgical Procedures
Primary: Predicted Percentage of Remaining Pulmonary Function — 73.4; 71.9 percentage of remaining function
COPD · Pre-Lung-Transplantation · Hypercapnia
Primary: Effects of a Multimodal Pulmonary Rehabilitation Program on 6 Minute Walking Distance (6MWD) — 35; 36 meter
COPD
Primary: Duration of Exercise Time on a Constant Work-rate Treadmill Test — 12.2; 12.5 change in number of minutes walked — p=0.94
Lung Cancer
Primary: Exercise Tolerance — 459.7; 341 Seconds
Asthma
Primary: Airway Wall Thickness — 1.5; 1.5; 1.4; 1.6 mm — p=0.2
COPD
Primary: Occurrence of Suboptimal PIFR — 22.7 percentage of participants
Heart Failure, Diastolic
Primary: Pulmonary Transit Time — 2.5 seconds
Cystic Fibrosis
Primary: Acute Study: Percentage Flow-Mediated Dilation (FMD) — 7.8; 7.7; 7.3; 6.6 percent flow mediated dilation
Alveolitis, Fibrosing · Fibrosis, Pulmonary · Hypertension, Pulmonary
Primary: Change in 6-minute Walk Test — -26; -7 meters
Non-Small Cell Lung Cancer
Primary: Pulmonary Function, Based on Changes in Tissue Elasticity Measured From 4DCT — 1.09; 1.13 ratio
Pulmonary Disease, Chronic Obstructive
Primary: Mean Change From Baseline in Right Ventricular End Diastolic Volume Index (RVEDVI) at the End of the Overall Treatment Period — -0.47; 5.35 Milliliter per meter square…
Mechanical Ventilation · Single-lung Ventilation · ARDS
Primary: Monitoring Capabilities of PulmoVista 500 — 0.9692; 0.9093 correlation coefficient
Single-ventricle
Primary: Change in Pulmonary Pulsatility Index — 51.6; 57.6 Ratio — p=0.1
Alpha-1 Antitrypsin Deficiency · Emphysema · Chronic Obstructive Pulmonary Disease
Primary: Pulmonary Microvascular Blood Flow, Mean — 36.9; 35.1 mL blood/minute per 100mL lung — p=0.692
Pulmonary Vascular Disease
Primary: Participants Determined to be True Positives for Pulmonary Arterial Hypertension — 10; 15; 10; 5 Participants
Cystic Fibrosis · Bronchiectasis
Primary: Tidal Volume (TV) Assessed in Participants at Baseline and With Both Devices — 0.79; 0.93; 1.12 L
COPD
Primary: DPI Responder Analysis in Patients With Suboptimal PIF (<60 L/Min) — 2; 1 Number of subject test days — p=0.33
Ventilation · Breathing · Atelectasis
Primary: Regional Distribution of Ventilation — -4.9; -5.6 percentage of dorsal redistribution — p=.90
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Patients With Therapeutic Success at Week 6 (Approx.) (Visit 2). — 51.52 Percentage of patients
Chronic Obstructive Pulmonary Disease · COPD
Primary: Baseline Resting Cardiac Index (CI) — 2.4; 2.36 L/min/m^2 — p=0.85